Show simple item record

dc.contributor.authorWilson, C
dc.contributor.authorRooshenas, L
dc.contributor.authorParamasivan, S
dc.contributor.authorElliott, D
dc.contributor.authorJepson, M
dc.contributor.authorStrong, S
dc.contributor.authorBirtle, A
dc.contributor.authorBeard, DJ
dc.contributor.authorHalliday, A
dc.contributor.authorHamdy, FC
dc.contributor.authorLewis, R
dc.contributor.authorMetcalfe, C
dc.contributor.authorRogers, CA
dc.contributor.authorStein, RC
dc.contributor.authorBlazeby, JM
dc.contributor.authorDonovan, JL
dc.date.accessioned2018-01-24T14:28:45Z
dc.date.issued2018-01-19
dc.identifier.citationTrials, 2018, 19 (1), pp. 50 - ?
dc.identifier.issn1745-6215
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1020
dc.identifier.eissn1745-6215
dc.identifier.doi10.1186/s13063-017-2413-6
dc.description.abstractBACKGROUND: Research has shown that recruitment to trials is a process that stretches from identifying potentially eligible patients, through eligibility assessment, to obtaining informed consent. The length and complexity of this pathway means that many patients do not have the opportunity to consider participation. This article presents the development of a simple framework to document, understand and improve the process of trial recruitment. METHODS: Eight RCTs integrated a QuinteT Recruitment Intervention (QRI) into the main trial, feasibility or pilot study. Part of the QRI required mapping the patient recruitment pathway using trial-specific screening and recruitment logs. A content analysis compared the logs to identify aspects of the recruitment pathway and process that were useful in monitoring and improving recruitment. Findings were synthesised to develop an optimised simple framework that can be used in a wide range of RCTs. RESULTS: The eight trials recorded basic information about patients screened for trial participation and randomisation outcome. Three trials systematically recorded reasons why an individual was not enrolled in the trial, and further details why they were not eligible or approached, or declined randomisation. A framework to facilitate clearer recording of the recruitment process and reasons for non-participation was developed: SEAR - Screening, to identify potentially eligible trial participants; Eligibility, assessed against the trial protocol inclusion/exclusion criteria; Approach, the provision of oral and written information and invitation to participate in the trial, and Randomised or not, with the outcome of randomisation or treatment received. CONCLUSIONS: The SEAR framework encourages the collection of information to identify recruitment obstacles and facilitate improvements to the recruitment process. SEAR can be adapted to monitor recruitment to most RCTs, but is likely to add most value in trials where recruitment problems are anticipated or evident. Further work to test it more widely is recommended.
dc.formatElectronic
dc.format.extent50 - ?
dc.languageeng
dc.language.isoeng
dc.publisherBMC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectTreatment Outcome
dc.subjectEndpoint Determination
dc.subjectSample Size
dc.subjectPatient Selection
dc.subjectEligibility Determination
dc.subjectRandomized Controlled Trials as Topic
dc.subjectClinical Decision-Making
dc.titleDevelopment of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
dc.typeJournal Article
dcterms.dateAccepted2017-12-14
rioxxterms.versionofrecord10.1186/s13063-017-2413-6
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-01-19
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfTrials
pubs.issue1
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.publication-statusPublished
pubs.volume19
pubs.embargo.termsNo embargo
icr.researchteamClinical Trials & Statistics Unit
dc.contributor.icrauthorLewis, Rebecca


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0